Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

500
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
500
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

914
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
914
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

510
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
510
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.5K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.5K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

279
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
279
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TREATMENT EFFECT HETEROGENEITY AND IMPORTANCE MEASURES FOR MULTIVARIATE CONTINUOUS TREATMENTS.

The annals of applied statistics·2026
Same author

Multivariate causal effects: a Bayesian causal regression factor model.

Biometrics·2026
Same author

Borrowing strength across exposures and outcomes via index models for multi-pollutant mixtures.

Biometrics·2026
Same author

Estimate an Exposure Response Function with Negative Controls: A Bayesian Nonparametric Approach.

American journal of epidemiology·2026
Same author

Health disparities and industrial emissions: a case study of semiconductor manufacturing and asthma morbidity in Austin, Texas.

Population and environment·2026
Same author

Potential biomarkers and preventative interventions for muscle wasting in adolescent and young adults with cancer: A translational study.

Scientific reports·2026

Related Experiment Video

Updated: Mar 5, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Guided Bayesian imputation to adjust for confounding when combining heterogeneous data sources in comparative

Joseph Antonelli1, Corwin Zigler1, Francesca Dominici1

  • 1Department of Biostatistics, Harvard TH Chan School of Public Health, 655 Huntington Avenue, Boston, MA, 02115,USA.

Biostatistics (Oxford, England)
|March 24, 2017
PubMed
Summary

This study introduces a Bayesian method to improve causal effect estimation in large observational studies with missing confounders by leveraging validation data. The approach enhanced confounding adjustment, reducing the estimated average causal effect by 30% in a brain tumor survival study.

Keywords:
Bayesian adjustment for confoundingBayesian data augmentationConfounder selectionMissing dataModel averaging

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K

Related Experiment Videos

Last Updated: Mar 5, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Health Services Research

Background:

  • Comparative effectiveness research often uses large observational data to estimate average causal effects.
  • Missing confounders in main studies necessitate advanced methods, as standard imputation may fail with limited validation data.

Purpose of the Study:

  • To propose a Bayesian approach for estimating average causal effects (ACE) in main studies with missing confounders.
  • To improve confounding adjustment by borrowing information from a smaller validation study.
  • To integrate Bayesian model averaging, confounder selection, and missing data imputation.

Main Methods:

  • Developed a Bayesian framework combining model averaging, confounder selection, and imputation.
  • Allowed for differential treatment effects between main and validation studies.
  • Propagated uncertainty from imputation and confounder selection in ACE estimation.

Main Results:

  • Simulations compared the proposed method against existing approaches.
  • Applied to Medicare data on brain tumor surgical resection and survival (10,396 main, 2220 validation).
  • Incorporating SEER-Medicare validation data reduced the estimated ACE by 30%.

Conclusions:

  • The Bayesian approach effectively enhances confounding adjustment in observational studies with missing covariate data.
  • Leveraging validation data significantly impacts causal effect estimates, highlighting the importance of comprehensive covariate information.
  • The method provides a robust framework for handling missing data and confounder uncertainty in comparative effectiveness research.